Issue 15, 2018, Issue in Progress

Adventures in radiosynthesis of clinical grade [68Ga]Ga-DOTA-Siglec-9

Abstract

We finally managed to establish a protocol for generating Good Manufacturing Practice (GMP)-grade gallium-68-labelled 1,4,7,0-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugated sialic acid-binding immunoglobulin-like lectin 9 motif containing peptide ([68Ga]Ga-DOTA-Siglec-9), the first radiopharmaceutical for positron emission tomography imaging of vascular adhesion protein 1.

Graphical abstract: Adventures in radiosynthesis of clinical grade [68Ga]Ga-DOTA-Siglec-9

Supplementary files

Article information

Article type
Paper
Submitted
20 Nov 2017
Accepted
08 Feb 2018
First published
20 Feb 2018
This article is Open Access
Creative Commons BY license

RSC Adv., 2018,8, 8051-8056

Adventures in radiosynthesis of clinical grade [68Ga]Ga-DOTA-Siglec-9

M. Käkelä, P. Luoto, T. Viljanen, H. Virtanen, H. Liljenbäck, S. Jalkanen, J. Knuuti, A. Roivainen and X. Li, RSC Adv., 2018, 8, 8051 DOI: 10.1039/C7RA12423F

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements